Michael Lai, M.D., is currently the Global Franchise Head for Lung Cancer Franchise and Datroway. Previously, Michael served as the General Manager for AstraZeneca China from 2019 to November 2024, managing multiple business units and contributing to significant sales growth. Prior roles include Project Leader at the Boston Consulting Group and various leadership positions at AstraZeneca and Sanofi, with a focus on oncology and other healthcare sectors. Michael holds a B.A. from Harvard University and an M.D. from the University of California, San Francisco, along with completed training in internal medicine and ophthalmology.
This person is not in any teams
This person is not in any offices